You are here

Article Text

Article menu
Download PDFPDF
ORIGINAL ARTICLE
Expression profile of ovarian tumors: distinct signature of Sertoli–Leydig cell tumor
  1. A. Baranova*,†,
  2. S. Gowder*,‡,
  3. S. Naouar*,
  4. S. King*,‡,
  5. K. Schlauch*,§,
  6. M. Jarrar*,
  7. Y. Ding*,‡,
  8. B. Cook†,
  9. V. Chandhoke*,† and
  10. A. Christensen*
  1. * Molecular Biology and Microbiology, George Mason University, Fairfax, Virginia
  2. † GMU-INOVA Translational Research Centers, George Mason University, Fairfax, Virginia
  3. ‡ American Type Culture Collection, Manassas, Virginia
  4. § Department of Genetics and Genomics, Boston University School of Medicine, Boston, Massachusetts
  1. Address correspondence and reprint request to: Dr Ancha Baranova, PhD, DSci, Molecular Biology and Microbiology, George Mason University, David King Hall, MSN 3E1, Fairfax, VA 22030, USA. Email: abaranov{at}gmu.edu

Abstract

Epithelial ovarian tumors are the most common subtype of ovarian cancer. In this study, we reveal distinct expression signatures of previously uncharacterized ovarian carcinoma subtypes, including endometrioid component of mixed ovarian tumor and Sertoli–Leydig tumor. Both subtypes were compared to the most common and well-characterized ovarian epithelial carcinoma of the serous type. These comparisons were performed by complementaryDNA (cDNA) microarrays allowing high-fidelity measurements of the expression levels of 39,360 human individual cDNA species representing both known and unknown human genes. Functional analysis of differentially expressed genes in Sertoli–Leydig tumor revealed an upregulation in sonic hedgehog pathway, deregulation of several metabolic pathways especially in amino acid metabolism and overexpression of genes associated with protein synthesis, including ribosomal genes.

  • cDNA microarray
  • expression profiling
  • ovarian carcinoma
  • Sertoli–Leydig tumor

https://doi.org/10.1111/j.1525-1438.2006.00732.x

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.